The genetics of vascular complications in autosomal dominant poly-cystic kidney disease (adpkd)

Current Hypertension Reviews

Volumn 9, Issue 1, 2013, Pages 37-43

  Rossetti, Sandro ^a   Harris, Peter C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adpkd; Genetic modifiers; Genotype phenotype correlations; Intracranial aneurysms

Indexed keywords

POLYCYSTIN 1; POLYCYSTIN 2;

ARTICLE; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MYOFIBROBLAST; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; TUNICA MEDIA;

ANIMALS; ENDOTHELIUM, VASCULAR; GENETIC ASSOCIATION STUDIES; HUMANS; INTRACRANIAL ANEURYSM; MUSCLE, SMOOTH, VASCULAR; MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; TRPP CATION CHANNELS;

EID: 84875321016     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/1573402111309010007     Document Type: Article

References (109)

1. Badano JL, Katsanis N. Beyond Mendel: an evolving view of human genetic disease transmission. Nat Rev Genet 2002; 3: 779-789.
2. Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet 2001; 2: 165-174.
3. Cutting GR. Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 2005; 6: 237-260.
4. Hateboer N, Lazarou L P, Williams AJ, Holmans P, Ravine D. Familial phenotype differences in PKD1. Kidney Int 1999; 56: 34-40.
5. Hateboer N, van Dijk MA, Bogdanova N, et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 1999; 353: 103-107.
6. Zerres K, Rudnik-Schöneborn S, Deget F, German working group on paediatric nephrology. Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. J Med Genet 1993; 30: 583-588.
7. Fick GM, Johnson AM, Strain JD, et al. Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1863-1870.
8. Torra R, Badenas C, Perez-Oller L, et al. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Am J Kidney Dis 2000; 36: 728-734.
9. Gabow PA, Johnson AM, Kaehny WD, et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992; 41: 1311-139.
10. Torres VE, Harris PC. Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities. J Intern Med 2007; 261: 17-31.
11. European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 1994; 77: 881-894.
12. Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-1342.
13. Rossetti S, Kubly VJ, Consugar MB, et al. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int 2009; 75: 848-855.
14. Hopp K, Ward CJ, Hommerding CJ, et al. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J Clin Invest 2012; 122: 4257-4273.
15. Paterson AD, Magistroni R, He N, et al. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2005; 16: 755-762.
16. Harris PC, Rossetti S. Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat Rev Nephrol 2010; 6:197-206.
17. Chapman AB, Rubinstein D, Hughes R, et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Eng J Med 1992; 327: 916-920.
18. Schievink W, Torres V, Wiebers D, Huston J, III. Intracranial arterial dolichoectasia in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1997; 8: 1298-1303.
19. Schievink WI. Intracranial aneurysms. N Engl J Med 1997; 336: 28-40.
20. Chauveau D, Pirson Y, Verellen-Dumoulin C, Macnicol A, Gonzalo A, Grünfeld J-P. Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 1994; 45: 1140-1146.
21. Bobrie G, Brunet-Bourgin F, Alamowitch S, et al. Spontaneous artery dissection: is it part of the spectrum of autosomal dominant polycystic kidney disease? Nephrol Dial Transplant 1998; 13: 2138-2141.
22. Irazabal M V, Huston J, 3rd, Kubly V, et al. Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6: 1274-1285.
23. Xu HW, Yu SQ, Mei CL, Li MH. Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 2011; 42: 204-206.
24. Gibbs F F, Huston III J, Qian Q, et al. Follow-up of intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 2004; 65:1621-1627.
25. Belz MM, Hughes RL, Kaehny WD, et al. Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2001; 38: 770-776.
26. Huston J, Torres VE, Sullivan P P, Offord K P, Wiebers DO. Value of magnetic resonance angiography for detection of intracranial aneurysm in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1871-1877.
27. Burns JD, Huston J, 3rd, Layton KF, Piepgras DG, Brown RD, Jr. Intracranial aneurysm enlargement on serial magnetic resonance angiography: frequency and risk factors. Stroke 2009; 40: 406-411.
28. Matsubara S, Hadeishi H, Suzuki A, Yasui N, Nishimura H. Incidence and risk factors for the growth of unruptured cerebral aneurysms: observation using serial computerized tomography angiography. J Neurosurg 2004; 101: 908-914.
29. Miyazawa N, Akiyama I, Yamagata Z. Risk factors for growth of unruptured intracranial aneurysms: follow-up study by serial 0.5-T magnetic resonance angiography. Neurosurgery 2006; 58: 1047-1053.
30. Wermer MJ, van der Schaaf IC, Velthuis BK, Majoie CB, Albrecht K W, Rinkel GJ. Yield of short-term follow-up CT/MR angiography for small aneurysms detected at screening. Stroke 2006; 37: 414-418.
31. Wiebers DO, Whisnant J P, Sundt TM, Jr., O'Fallon WM. The significance of unruptured intracranial saccular aneurysms. J Neurosurg 1987; 66: 23-29
32. Griffin MD, Torres VE, Grande J P, Kumar R. Vascular expression of polycystin. J Am Soc Nephrol 1997; 8: 616-626.
33. Torres VE, Cai Y, Chen X, et al. Vascular expression of polycystin 2. J Am Soc Nephrol 2001; 12: 1-9.
34. Ibraghimov-Beskrovnaya O, Dackowski WR, Foggensteiner L, et al. Polycystin: In vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci USA 1997; 94: 6397-6402.
35. Sharif-Naeini R, Folgering JH, Bichet D, et al. Polycystin-1 and -2 dosage regulates pressure sensing. Cell 2009; 139: 587-596.
36. Qian Q, Li M, Cai Y, et al. Analysis of the polycystins in aortic vascular smooth muscle cells. J Am Soc Nephrol 2003; 14: 2280-22287.
37. Qian Q, Hunter LW, Li M, et al. PKD2 haploinsufficiency alters intracellular calcium in vascular smooth muscle cells. Hum Mol Genet 2003; 12: 1875-1880.
38. Hassane S, Claij N, Lantinga-van Leeuwen IS, et al. Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse model. Arterioscler Thromb Vasc Biol 2007; 27: 2177-2183.
39. Schievink WI, Torres VE, Piepgras DG, Wiebers DO. Saccular intracranial aneurysms in autosomal dominant polycystic disease. J Am Soc Nephrol 1992; 3: 88-95.
40. van Dijk MA, Chang PC, Peters DJM, Breuning MH. Intracranial aneurysms in polycystic kidney disease linked to chromosome 4. J Am Soc Nephrol 1995; 6: 1670-1673.
41. Rossetti S, Strmecki L, Gamble V, et al. Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet 2001; 68: 46-63.
42. Rossetti S, Chauveau D, Walker D, et al. A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int 2002; 61: 1588-1599.
43. Rossetti S, Consugar MB, Chapman AB, et al. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2007; 18: 2143-2160.
44. Veldhuisen B, Saris JJ, de Haij S, et al. A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). Am J Hum Genet 1997; 61: 547-55.
45. Watnick T, Phakdeekitcharoen B, Johnson A, et al. Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease. Am J Hum Genet 1999; 65: 1561-1571.
46. ADPKD. Autosomal Dominant Polycystic Kidney Disease: Mutation Database; http://pkdb.mayo.edu, 2010. PKD Foundation.
47. Harris P, Rossetti S. Molecular diagnostics of autosomal dominant polycystic kidney disease (ADPKD). Nature Rev Nephrol 2010; 6: 197-206.
48. Rossetti S, Chauveau D, Kubly V, et al. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 2003; 361: 2196-2201.
49. Ponting C P, Hofmann K, Bork P. A latrophilin/CL-1-like GPS domain in polycystin-1. Curr Biol 1999; 9: R585-R588.
50. Qian F, Boletta A, Bhunia AK, et al. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1- associated mutations. Proc Natl Acad Sci USA 2002; 99: 16981-16986.
51. Atkinson JL, Sundt TM, Jr., Houser OW, Whisnant JP. Angiographic frequency of anterior circulation intracranial aneurysms. J Neurosurg 1989; 70: 551-555.
52. Winn HR, Taylor J, Kaiser D. Prevalence of asymptomatic incidental aneurysms: Review of 4,568 arteriograms. Stroke 1983; 4: 121.
53. McCormick WF, Nofzinger JD. Saccular Intracranial Aneurysms: An Autopsy Study. J Neurosurg 1965; 22: 155-9.
54. Inagawa T, Hirano A. Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol 1990; 34: 361-365.
55. Inagawa T, Hirano A. Ruptured intracranial aneurysms: an autopsy study of 133 patients. Surg Neurol 1990; 33: 117-123.
56. Schievink WI, Wijdicks EF, Parisi JE, Piepgras DG, Whisnant J P. Sudden death from aneurysmal subarachnoid hemorrhage. Neurology 1995; 45: 871-874.
57. Phillips LH, 2nd, Whisnant JP, O'Fallon WM, Sundt TM, Jr. The unchanging pattern of subarachnoid hemorrhage in a community. Neurology 1980; 30: 1034-1040.
58. Sacco RL, Wolf PA, Bharucha NE, et al. Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology 1984; 34: 847-854.
59. Longstreth WT, Jr., Nelson LM, Koepsell TD, van Belle G. Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology 1993; 43: 712-718.
60. Fogelholm R, Hernesniemi J, Vapalahti M. Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 1993; 24: 1649-1654.
61. Inagawa T, Tokuda Y, Ohbayashi N, Takaya M, Moritake K. Study of aneurysmal subarachnoid hemorrhage in Izumo City, Japan. Stroke 1995; 26: 761-766.
62. Schievink WI, Schaid DJ, Rogers HM, Piepgras DG, Michels VV. On the inheritance of intracranial aneurysms. Stroke 1994; 25: 2028-2037.
63. Schievink WI, Michels V V, Piepgras DG. Neurovascular manifestations of heritable connective tissue disorders: A review. Stroke 1994; 25: 889-903.
64. Chambers WR, Harper BF, Jr., Simpson JR. Familial incidence of congenital aneurysms of cerebral arteries: report of cases of ruptured aneurysms in father and son. J Am Med Assoc 1954; 155: 358-359.
65. Norrgard O, Angquist KA, Fodstad H, Forsell A, Lindberg M. Intracranial aneurysms and heredity. Neurosurgery 1987; 20: 236-239.
66. Ronkainen A, Hernesniemi J, Puranen M, et al. Familial intracranial aneurysms. Lancet 1997; 349: 380-4.
67. Ronkainen A, Hernesniemi J, Ryynanen M. Familial subarachnoid hemorrhage in east Finland, 1977-1990. Neurosurgery 1993; 33: 787-796; discussion 96-97.
68. Schievink WI, Schaid DJ, Michels V V, Piepgras DG. Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg 1995; 83: 426-429.
69. De Braekeleer M, Perusse L, Cantin L, Bouchard JM, Mathieu J. A study of inbreeding and kinship in intracranial aneurysms in the Saguenay Lac-Saint-Jean region (Quebec, Canada). Ann Hum Genet 1996; 60: 99-104.
70. Bromberg JE, Rinkel GJ, Algra A, et al. Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ 1995; 311: 288-289.
71. Nahed BV, Bydon M, Ozturk AK, Bilguvar K, Bayrakli F, Gunel M. Genetics of intracranial aneurysms. Neurosurgery 2007; 60: 213-225; discussion 25-26.
72. Ruigrok YM, Rinkel GJ. Genetics of intracranial aneurysms. Stroke 2008; 39: 1049-1055.
73. Ruigrok YM, Rinkel GJ, Wijmenga C. Genetics of intracranial aneurysms. Lancet Neurol 2005; 4: 179-189.
74. Ruigrok YM, Elias R, Wijmenga C, Rinkel GJ. A comparison of genetic chromosomal loci for intracranial, thoracic aortic, and abdominal aortic aneurysms in search of common genetic risk factors. Cardiovasc Pathol 2008; 17: 40-47.
75. Bilguvar K, Yasuno K, Niemela M, et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 2008; 40: 1472-1477.
76. Yasuno K, Bilguvar K, Bijlenga P, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 2010; 42: 420-425.
77. Visel A, Zhu Y, May D, et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010; 464: 409-412.
78. Matsui T, Kanai-Azuma M, Hara K, et al. Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice. J Cell Sci 2006; 119: 3513-3526.
79. Sakamoto Y, Hara K, Kanai-Azuma M, et al. Redundant roles of Sox17 and Sox18 in early cardiovascular development of mouse embryos. Biochem Biophys Res Commun 2007; 360: 539-544.
80. Kim I, Saunders TL, Morrison SJ. Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells. Cell 2007; 130: 470-483.
81. Janzen V, Forkert R, Fleming HE, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006; 443: 421-426.
82. Yun MH, Hiom K. CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature 2009; 459: 460-463.
83. Leung TH, Ching Y P, Yam J W, et al. Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. Proc Natl Acad Sci USA 2005; 102: 15207-15212.
84. Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006; 444: 770-774.
85. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45-51.
86. Thompson AR, Golledge J, Cooper JA, Hafez H, Norman PE, Humphries SE. Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion. Eur J Hum Genet 2009; 17: 391-394.
87. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316: 1491-1493.
88. Pasmant E, Sabbagh A, Vidaud M, Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011; 25: 444-448.
89. Gretarsdottir S, Baas AF, Thorleifsson G, et al. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet 2010; 42: 692-697.
90. Yoneyama T, Kasuya H, Onda H, et al. Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm. J Hum Genet 2003; 48: 309-314.
91. Ruigrok YM, Rinkel GJ, van't Slot R, Wolfs M, Tang S, Wijmenga C. Evidence in favor of the contribution of genes involved in the maintenance of the extracellular matrix of the arterial wall to the development of intracranial aneurysms. Hum Mol Genet 2006; 15: 3361-3368.
92. Krischek B, Inoue I. The genetics of intracranial aneurysms. J Hum Genet 2006; 51: 587-94.
93. Woo D, Broderick J. Genetics of intracranial aneurysm. J Stroke Cerebrovasc Dis 2002; 11: 230-240.
94. Ruigrok YM, Rinkel GJ, Wijmenga C. The versican gene and the risk of intracranial aneurysms. Stroke 2006; 37: 2372-2374.
95. Shi C, Awad IA, Jafari N, et al. Genomics of human intracranial aneurysm wall. Stroke 2009; 40: 1252-1261.
96. Zhang B, Fugleholm K, Day LB, Ye S, Weller RO, Day IN. Molecular pathogenesis of subarachnoid haemorrhage. Int J Biochem Cell Biol 2003; 35: 1341-1360.
97. Santiago-Sim T, Mathew-Joseph S, Pannu H, et al. Sequencing of TGF-beta pathway genes in familial cases of intracranial aneurysm. Stroke 2009; 40: 1604-11.
98. Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006; 355: 788-798.
99. Pezzini A, Drera B, Del Zotto E, et al. Mutations in TGFBR2 gene cause spontaneous cervical artery dissection. J Neurol Neurosurg Psychiatry 2011; 82: 1372-1374.
100. Ruigrok YM, Tan S, Medic J, Rinkel GJ, Wijmenga C. Genes involved in the transforming growth factor beta signalling pathway and the risk of intracranial aneurysms. J Neurol Neurosurg Psychiatry 2008; 79: 722-724.
101. van de Laar IM, Oldenburg RA, Pals G, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 2011; 43: 121-126.
102. Tromp G, Wu Y, Prockop DJ, et al. Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest 1993; 91: 2539-2545.
103. Jeanne M, Labelle-Dumais C, Jorgensen J, et al. COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet 2012; 90: 91-101.
104. Plaisier E, Chen Z, Gekeler F, et al. Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. Am J Med Genet A 2010; 152A: 2550-2555.
105. Plaisier E, Gribouval O, Alamowitch S, et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 2007; 357: 2687-2695.
106. Lanfranconi S, Markus HS. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke 2010; 41: e513-e518.
107. Borck G, Beighton P, Wilhelm C, Kohlhase J, Kubisch C. Arterial rupture in classic Ehlers-Danlos syndrome with COL5A1 mutation. Am J Med Genet A 2010; 152A: 2090-2093.
108. Peck G, Smeeth L, Whittaker J, Casas J P, Hingorani A, Sharma P. The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults. PLoS One 2008; 3: e3691.
109. Rossetti S, Irazabal M V, Hopp K, et al. Analysis of the genomic profile associated with the development of a vascular phenotype in autosomal dominant polycystic kidney disease. J Am Soc Neph 2012; 23: 699A.